1. Home
  2. HSIC vs CRL Comparison

HSIC vs CRL Comparison

Compare HSIC & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Henry Schein Inc.

HSIC

Henry Schein Inc.

HOLD

Current Price

$79.57

Market Cap

8.6B

Sector

Health Care

ML Signal

HOLD

Logo Charles River Laboratories International Inc.

CRL

Charles River Laboratories International Inc.

HOLD

Current Price

$169.90

Market Cap

8.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HSIC
CRL
Founded
1932
1947
Country
United States
United States
Employees
N/A
20100
Industry
Medical Specialities
Biotechnology: Commercial Physical & Biological Resarch
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.6B
8.3B
IPO Year
1996
1999

Fundamental Metrics

Financial Performance
Metric
HSIC
CRL
Price
$79.57
$169.90
Analyst Decision
Hold
Buy
Analyst Count
13
12
Target Price
$76.00
$199.64
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
01-01-0001
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.42
N/A
Revenue
$13,201,995,000.00
$1,857,601,000.00
Revenue This Year
$5.33
$2.51
Revenue Next Year
$3.41
$4.66
P/E Ratio
$32.88
N/A
Revenue Growth
5.94
10.48
52 Week Low
$60.56
$91.86
52 Week High
$82.80
$228.88

Technical Indicators

Market Signals
Indicator
HSIC
CRL
Relative Strength Index (RSI) 47.52 32.93
Support Level $73.08 $146.33
Resistance Level $79.15 $164.36
Average True Range (ATR) 2.37 10.68
MACD -0.18 -3.27
Stochastic Oscillator 37.35 27.56

Price Performance

Historical Comparison
HSIC
CRL

About HSIC Henry Schein Inc.

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology. It generates the majority of its revenue from the Global Distribution and Value-Added Services segment, which includes distribution to the dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.

About CRL Charles River Laboratories International Inc.

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Share on Social Networks: